Epstein Becker Green drafted a letter to the Drug Enforcement Administration (DEA) on behalf of an academic institution regarding the DEA’s fee-waiver rule
Health Care Law, Workforce Management Lawyer, Litigation Attorney
DEA Fee-Waiver Rule
February 5, 2021 | Health Care